Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 10-2004 | 09-2004 | 07-2004 | 06-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,887 | 1,324 | -21,004 | 1,112 | -13,997 |
| Depreciation Amortization | 5,730 | 484 | 11,079 | 330 | 6,786 |
| Accounts receivable | 143 | -528 | -87 | -819 | 125 |
| Accounts payable and accrued liabilities | 36 | -1,123 | 522 | -1,283 | 365 |
| Other Working Capital | 889 | -2,235 | 1,376 | -2,149 | 678 |
| Other Operating Activity | 2,849 | 1,511 | 2,896 | 1,962 | 2,171 |
| Operating Cash Flow | $-7,240 | $-567 | $-5,218 | $-847 | $-3,872 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -7,934 | N/A | -6,009 | N/A | -4,969 |
| PPE Investments | -150 | -292 | -1,689 | -148 | -143 |
| Sale Of Investment | 1,496 | N/A | 1,496 | N/A | 1,496 |
| Purchase Sale Intangibles | -208 | N/A | -168 | N/A | -121 |
| Other Investing Activity | -208 | 0 | 1,378 | 0 | -121 |
| Investing Cash Flow | $-6,796 | $-292 | $-4,824 | $-148 | $-3,737 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | -494 | N/A | -400 | N/A |
| Debt Issued | 7,550 | 3,212 | 7,550 | 621 | 5,808 |
| Debt Repayment | N/A | -2,576 | N/A | -70 | N/A |
| Common Stock Issued | 12,077 | N/A | 12,083 | N/A | 2,911 |
| Other Financing Activity | -542 | 0 | -550 | 0 | -410 |
| Financing Cash Flow | $19,085 | $142 | $19,083 | $151 | $8,309 |
| Beginning Cash Position | 3,764 | 1,276 | 3,764 | 1,276 | 3,764 |
| End Cash Position | 8,813 | 559 | 12,805 | 432 | 4,464 |
| Net Cash Flow | $5,049 | $-717 | $9,041 | $-844 | $700 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,240 | -567 | -5,218 | -847 | -3,872 |
| Capital Expenditure | -150 | -292 | -1,689 | -148 | -143 |
| Free Cash Flow | -7,390 | -859 | -6,907 | -995 | -4,015 |